ZA872925B - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
ZA872925B
ZA872925B ZA872925A ZA872925A ZA872925B ZA 872925 B ZA872925 B ZA 872925B ZA 872925 A ZA872925 A ZA 872925A ZA 872925 A ZA872925 A ZA 872925A ZA 872925 B ZA872925 B ZA 872925B
Authority
ZA
South Africa
Prior art keywords
compounds
heterocyclic compounds
hydrogen
formula
broncho
Prior art date
Application number
ZA872925A
Other languages
English (en)
Inventor
William John Coates
John Coates William
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of ZA872925B publication Critical patent/ZA872925B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
ZA872925A 1986-04-28 1987-04-24 Heterocyclic compounds ZA872925B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868610369A GB8610369D0 (en) 1986-04-28 1986-04-28 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ZA872925B true ZA872925B (en) 1987-11-25

Family

ID=10596986

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872925A ZA872925B (en) 1986-04-28 1987-04-24 Heterocyclic compounds

Country Status (9)

Country Link
EP (1) EP0247724B1 (de)
JP (1) JPS62258378A (de)
AT (1) ATE67197T1 (de)
AU (1) AU586089B2 (de)
DE (1) DE3772850D1 (de)
DK (1) DK210387A (de)
GB (1) GB8610369D0 (de)
PT (1) PT84760B (de)
ZA (1) ZA872925B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314400A1 (de) * 1987-10-24 1989-05-03 Smith Kline & French Laboratories Limited Therapeutisch wirksame kondensierte Thiadiazinone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1292645B (de) * 1965-11-12 1969-04-17 Hoechst Ag Verfahren zur Herstellung substituierter Thiocarbaminsaeureester
DE3172252D1 (en) * 1980-11-14 1985-10-17 Ici Plc Heterocyclic compounds
US4602019A (en) * 1983-04-22 1986-07-22 Warner-Lambert Company Indeno[1,2-c]pyridazin-3-one derivatives useful as cardiotonic and antihypertensive agents
GB8329784D0 (en) * 1983-11-08 1983-12-14 Smith Kline French Lab Heterocyclic compounds
ES2031821T3 (es) * 1985-10-17 1993-01-01 Smith Kline & French Laboratories Limited Procedimiento para preparar derivados de 4(4-oxo-1,4-dihidropiridin-1-il)fenilo.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314400A1 (de) * 1987-10-24 1989-05-03 Smith Kline & French Laboratories Limited Therapeutisch wirksame kondensierte Thiadiazinone
WO1989003832A1 (en) * 1987-10-24 1989-05-05 Smith Kline & French Laboratories Limited Therapeutically active condensed thiadiazinones

Also Published As

Publication number Publication date
DK210387D0 (da) 1987-04-24
EP0247724A1 (de) 1987-12-02
DE3772850D1 (de) 1991-10-17
EP0247724B1 (de) 1991-09-11
DK210387A (da) 1987-10-29
PT84760A (en) 1987-05-01
AU586089B2 (en) 1989-06-29
AU7195487A (en) 1987-10-29
PT84760B (pt) 1989-12-29
ATE67197T1 (de) 1991-09-15
GB8610369D0 (en) 1986-06-04
JPS62258378A (ja) 1987-11-10

Similar Documents

Publication Publication Date Title
EP0150937A3 (en) Dihydropyridazinones
IL80213A (en) Quinazoline derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
ES8404360A1 (es) Un procedimiento para preparar compuestos de cefem.
PT84760A (en) Heterocyclic compounds
IL79280A (en) 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them